OTCMKTS:INBP Integrated BioPharma (INBP) Stock Price, News & Analysis $0.18 +0.02 (+12.69%) As of 02:56 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsSEC Filings About Integrated BioPharma Stock (OTCMKTS:INBP) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Integrated BioPharma alerts:Sign Up Key Stats Today's Range$0.18▼$0.1950-Day Range$0.15▼$0.1952-Week Range$0.14▼$0.42Volume47,612 shsAverage Volume4,428 shsMarket Capitalization$5.64 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Integrated BioPharma, Inc. is a health and wellness company focused on the development, manufacturing and distribution of nutritional supplements, vitamins, herbal products and related consumer health offerings. The company serves businesses and consumers seeking products in the dietary supplement and natural health categories. Its activities have included contract manufacturing and private-label production, as well as the sale and distribution of finished nutritional and wellness products. These capabilities may include formulation, manufacturing, packaging and related services for supplement companies and other customers. Integrated BioPharma has historically operated in the United States and has served customers through domestic and international distribution channels. Publicly available information about its current operating structure, principal brands and leadership is limited, so additional details cannot be stated reliably.AI Generated. May Contain Errors. Read More Receive INBP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Integrated BioPharma and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. INBP Stock News HeadlinesIntegrated Biopharma’s Wholly-Owned Subsidiary, Manhattan Drug Company, Inc. Appoints Michael Richtmyer as Head of OperationsAugust 20, 2026 | usatoday.comIntegrated BioPharma, Inc.: Integrated BioPharma Reports Results for Its Quarter Ended December 31, 2025February 11, 2026 | finanznachrichten.deSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor. This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely.September 21 at 1:00 AM | Altimetry (Ad)Integrated BioPharma Holds 2025 Annual Stockholder MeetingDecember 10, 2025 | theglobeandmail.comRentschler Biopharma and Coriolis Pharma announce strategic collaboration for integrated biopharma solutionsDecember 2, 2025 | globenewswire.comINBP Integrated BioPharma, Inc.June 15, 2025 | seekingalpha.comIntegrated BioPharma Secures New Credit Line with PNCApril 21, 2025 | tipranks.comIntegrated Biopharma Inc (INBP)August 31, 2024 | investing.comSee More Headlines INBP Stock Analysis - Frequently Asked Questions How have INBP shares performed this year? Integrated BioPharma's stock was trading at $0.3550 at the start of the year. Since then, INBP stock has decreased by 48.7% and is now trading at $0.1821. How were Integrated BioPharma's earnings last quarter? Integrated BioPharma Inc. (OTCMKTS:INBP) announced its quarterly earnings results on Friday, May, 8th. The company reported ($0.03) EPS for the quarter. The business had revenue of $10.11 million for the quarter. Integrated BioPharma had a negative trailing twelve-month return on equity of 8.32% and a negative net margin of 3.43%. How do I buy shares of Integrated BioPharma? Shares of INBP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Integrated BioPharma own? Based on aggregate information from My MarketBeat watchlists, some other companies that Integrated BioPharma investors own include GSK (GSK), Invitae (NVTA), ExxonMobil (XOM), Autodesk (ADSK), Adaptive Biotechnologies (ADPT), Analog Devices (ADI) and Adaptimmune Therapeutics (ADAP). Company Calendar Last Earnings5/08/2026Today9/21/2026Fiscal Year End6/30/2027Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:INBP CIK1016504 Webir.ibiopharma.com Phone(973) 926-0816Fax973-926-1735Employees153Year Founded1995Profitability EPS (Trailing Twelve Months)($0.07) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$810 thousand Net Margins-3.43% Pretax Margin-2.32% Return on Equity-8.32% Return on Assets-6.57% Debt Debt-to-Equity RatioN/A Current Ratio3.25 Quick Ratio1.78 Sales & Book Value Annual Sales$54.35 million Price / Sales0.10 Cash Flow$0.08 per share Price / Cash Flow2.41 Book Value$0.66 per share Price / Book0.28Miscellaneous Outstanding Shares30,980,000Free Float10,098,000Market Cap$5.64 million OptionableNot Optionable Beta0.40 Social Links 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (OTCMKTS:INBP) was last updated on 9/21/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Integrated BioPharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Integrated BioPharma With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
